Hetero launches generic COVID-19 drug at Rs 59 per tablet

Drug firm Hetero on Wednesday said it has launched generic oral antiviral drug Favipiravir used for the treatment of patients with mild to moderate COVID-19, in India under the brand name 'Favivir'......

Modi first foreign head to get Bhutan's highest civilian honour

Prime Minister Narendra Modi on Friday received Bhutan's highest civilian award, the 'Order of the Druk Gyalpo', making him the first foreign Head of the Government to receive the honour. IMAGE:......

'Follow zero tolerance': Health minister on cough syrup deaths

Asserting that India follows a zero-tolerance policy on spurious medicines, Union health minister Mansukh Mandaviya has said 71 companies have been issued show-cause notices following concerns......

India should spend $1 bn annually to train school teachers: Narayana Murthy

Software icon NR Narayana Murthy on Wednesday called for spending $1 billion a year to train school teachers by 10,000 retired highly accomplished teachers from the developed world and from India......

Sun Pharma Q2 net profit up 3% at Rs 3,118 cr

Sun Pharmaceutical Industries on Wednesday posted a 2.56 per cent increase in its consolidated net profit to Rs 3,118 crore for the second quarter ended September 30, aided by robust sales in India......

Cipla Q2 profit up 3.7% at Rs 1,353 cr

Pharma major Cipla Ltd on Thursday reported a 3.7 per cent rise in consolidated net profit at Rs 1,353.37 crore for the second quarter ended September 30, 2025. Photograph: Danish Siddiqui/Reuters......

Trump's 100% tariff on pharma unlikely to hurt domestic industry: Experts

US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 is unlikely to have an immediate impact on Indian exports, as it will affect only......

Generic industry unlikely to be affected by Trump's EO: Indian drug cos

A fresh US executive order (EO) which seeks to bring down prices of prescription drugs in the country by up to 90 per cent -- on par with other developed nations -- will affect innovator companies,......